An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT00488631 · COMPLETED
Trial details
- NCT number
- NCT00488631
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2011-10-01
- Enrollment
- 1228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.